Larimar Therapeutics | Investor Presentation Deck | 44 slides · page 14 of 44
The slide highlights high completion rates and manageable adverse events, specifically noting injection site reactions (ISRs) as the most common side effect.
Pitch deck · appendix_data · analyze_data · overcrowded density
Slide locked Sign in to view
Slide schematic 7/7
list 4/4 paragraph 1/1 source-note 1/1 title 1/1
Components 7
bullet bullet bullet bullet paragraph source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.